Author: Rekha Reddipalli

Generative AI and human memory
Generative AI Unravels the Secrets of Memory and Imagination

A recent study by UCL researchers reveals that breakthroughs in generative AI shed light on.

Irritable Bowel Syndrome
Irritable Bowel Syndrome Patients at Elevated Risk for Fibromyalgia and Chronic Fatigue Syndrome

A connection between irritable bowel syndrome (IBS) and somatic disorders, such as fibromyalgia and chronic.

rheumatoid arthritis in women
Study Identifies Hormonal and Reproductive Triggers for Rheumatoid Arthritis

A comprehensive long-term study published in the open-access journal RMD Open reveals that women who.

Lung transplant
Research Shows Better Lung Transplant Survival Rates

Researchers at the University Of Virginia School Of Medicine have discovered a potential method to.

COVID-19 and Long-Term Acute Kidney Failure
Decoding COVID-19 and Long-Term Acute Kidney Failure

New research from UC Davis Health has some good news about COVID-19 and kidney health..

sickle cell disease and pregnancy complications
What is the Role of Sickle Cell Disease in Pregnancy?

More moms with sickle cell disease (SCD) face pregnancy problems like cesarean delivery and preeclampsia.

liquid biopsy and immunotherapy predictions
How Liquid Biopsy Predicts Immunotherapy Success in Advanced Lung Cancer?

Researchers at the Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy, and.

revolutionizing immunization studies and vaccine development
Vaccine Development – Epitope Display in Mammal Cells Reshapes Immunization Studies

A recent publication in Biology Methods & Protocols highlights the creation of a novel epitope.

CBD Reduces Inflammation
CBD Role in Reducing Inflammation in HIV-Affected Brain Cells

CBD shows promise as a potential therapeutic option for individuals with HIV. Despite the efficacy.

cell therapy in lymphoma remission
Study Validates Safety and Effectiveness of Cell Therapy in Lymphoma Remission

A recent investigation explores the effectiveness of CAR T immunotherapy in individuals who achieved lymphoma.